Erie Indemnity (ERIE)
(Delayed Data from NSDQ)
$506.30 USD
+10.35 (2.09%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $520.01 +13.71 (2.71%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$506.30 USD
+10.35 (2.09%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $520.01 +13.71 (2.71%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth C Momentum D VGM
Zacks News
Erie Indemnity (ERIE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 17.80% and 4.49%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).
Arthur J. Gallagher (AJG) Shares Up 31% YTD: More Upside Left?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment continue to drive Arthur J. Gallagher (AJG).
Should You Retain Willis Towers (WTW) Stock in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growing healthcare premiums, increased consulting work and software sales, strategic buyouts and effective capital deployment.
Best Income Stocks to Buy for June 9th
by Zacks Equity Research
CCU, AMR and ERIE made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 9, 2023.
What Makes Erie Indemnity (ERIE) a New Strong Buy Stock
by Zacks Equity Research
Erie Indemnity (ERIE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Brown & Brown (BRO) Gains 10% YTD: Will the Rally Continue?
by Zacks Equity Research
New businesses, better customer retention, premium rate increases across the majority of business lines, strategic acquisitions and strong financial position continue to drive Brown & Brown (BRO)
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty
by Zacks Equity Research
Marsh & McLennan, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, BRO, ERIE and RYAN.
Arthur J. Gallagher (AJG) Expands Brokerage Business With Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) boosts its brokerage and consulting business with Bernard Benefits and Bernard Healthcare Financial Planning acquisition.
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Stock
by Zacks Equity Research
Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.
Erie Indemnity (ERIE) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Erie Indemnity (ERIE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Here's Why You Should Hold Aflac (AFL) in Your Portfolio
by Zacks Equity Research
Lower benefits and expenses, higher net investment income, and improved profit levels from the U.S. business aid Aflac (AFL).
Arthur J. Gallagher (AJG) Boosts Capabilities With IBKB Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Insurance by Ken Brown acquisition will help consolidate its presence in Florida and Southeast United States.
Brown & Brown (BRO) to Expand UK Presence With Buyout
by Zacks Equity Research
Brown & Brown's (BRO) pending Kentro Capital Limited acquisition will help it boost presence London.
Arthur J. Gallagher (AJG) on a Buyout Spree, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyouts help it solidify geographical presence as well as consolidate portfolio.
Looking for a Growth Stock? 3 Reasons Why Erie Indemnity (ERIE) is a Solid Choice
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Brown & Brown (BRO) Acquires Brownlee Agency, Boosts Portfolio
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Brownlee Agency is likely to strengthen the insurance broker's capabilities and expand its presence in Georgia.
Best Income Stocks to Buy for May 3rd
by Zacks Equity Research
SCMWY, MITSY and ERIE made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 3, 2023.
Erie Indemnity (ERIE) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 5.77% and 6.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Marsh & McLennan (MMC) Q4 Earnings Top Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 5% and 4.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Erie Indemnity (ERIE) OK's Dividend Hike to Share More Profits
by Zacks Equity Research
Erie Indemnity's (ERIE) recent dividend hike reflects its solid capital position and balance sheet strength that continue to support effective capital deployment.
Brown & Brown (BRO) Acquires Finance Builders, Boosts Portfolio
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Finance Builders is expected to strengthen the presence of Brown & Brown Dealer Services (BBDS) in Connecticut and Massachusetts.
Arthur J. Gallagher (AJG) Expands in Ireland With Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of Doyle Mahon Insurances is likely to expand the acquirer's presence in Ireland and provide it with better growth opportunities.
Erie Indemnity (ERIE) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Erie Indemnity (ERIE) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.